Home/Filings/4/0000842023-11-000016
4//SEC Filing

VERONNEAU MARCEL 4

Accession 0000842023-11-000016

CIK 0000842023other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 11:23 AM ET

Size

17.2 KB

Accession

0000842023-11-000016

Insider Transaction Report

Form 4
Period: 2011-05-26
VERONNEAU MARCEL
VP-Hematology Operations
Transactions
  • Sale

    Common Stock

    2011-05-26$81.20/sh505$41,00434,569 total
  • Exercise/Conversion

    Stock Option

    2011-05-265050 total
    Exercise: $40.47From: 2004-07-09Exp: 2011-07-08Common Stock (505 underlying)
  • Exercise/Conversion

    Common Stock

    2011-05-26$40.47/sh+505$20,43735,074 total
Holdings
  • Stock Option

    Exercise: $62.46From: 2009-07-24Exp: 2016-07-23Common Stock (494 underlying)
    494
  • Stock Option

    Exercise: $51.60From: 2005-08-18Exp: 2012-08-17Common Stock (475 underlying)
    475
  • Stock Option

    Exercise: $66.25From: 2011-04-30Exp: 2017-04-29Common Stock (10,000 underlying)
    10,000
  • Common Stock

    (indirect: by Stock Bonus Plan)
    6,702
  • Stock Option

    Exercise: $79.41From: 2008-07-25Exp: 2015-07-24Common Stock (385 underlying)
    385
  • Stock Option

    Exercise: $56.83From: 2007-07-27Exp: 2014-07-26Common Stock (510 underlying)
    510
  • Stock Option

    Exercise: $49.43From: 2006-07-27Exp: 2013-07-27Common Stock (567 underlying)
    567
  • Stock Option

    Exercise: $58.40From: 2010-07-30Exp: 2017-07-29Common Stock (1,281 underlying)
    1,281
Footnotes (1)
  • [F1]Vested 5,000 each 4/30/11 and 4/30/12.

Issuer

TECHNE CORP /MN/

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001213074

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 11:23 AM ET
Size
17.2 KB